ARCHIVES

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Susan Blumenthal Said To Be Candidate For Surgeon General

June 12, 2009

Panel Considers Easing Comp Center Independence Requirement, but Realizes It Lacks That Authority

February 18, 1977

Clinical Nutrition Academic Award Concept Approved

October 4, 1985

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

October 18, 2002

NIH Advisors Urge Stronger Peer Review, Clinical Center Renewal

May 20, 1994

Guest Editorial – Power Shifts to Communities

January 9, 1976